Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters

A Study to Investigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Medications in Adults With Focal Onset Seizures

NCT05159908 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters

NCT01390220 ·Status: TERMINATED ·Phase: PHASE3

Extension Study to Evaluate the Safety and Tolerability of NBI-921352 When Used With Anti-seizure Medications in Adults With Focal Onset Seizures

NCT05493293 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic Seizures

NCT02408549 ·Status: COMPLETED ·Phase: PHASE3

Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

NCT01118949 ·Status: COMPLETED ·Phase: PHASE2

A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy

NCT02495844 ·Status: COMPLETED ·Phase: PHASE2

To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

NCT00552305 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures

NCT00655486 ·Status: COMPLETED ·Phase: PHASE3

Naturalistic Study to Evaluate the Utilization of Care Services Associated to the Diagnostic Process of Any Kind of Epilepsy

NCT00522522 ·Status: COMPLETED

Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure

NCT01235403 ·Status: COMPLETED ·Phase: PHASE4

Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.

NCT00175864 ·Status: WITHDRAWN ·Phase: PHASE3

Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures

NCT01261325 ·Status: COMPLETED ·Phase: PHASE3

A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice

NCT00855738 ·Status: COMPLETED ·Phase: PHASE4

Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures

NCT00522275 ·Status: COMPLETED ·Phase: PHASE3

Study to Test the Efficacy and Safety of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adults With Drug-resistant Epilepsy

NCT03373383 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

NCT01422720 ·Status: COMPLETED ·Phase: PHASE3

Prospective Open-label Evaluation of Cenobamate Adjunctive Treatment of Adults With Refractory Focal Epilepsy

NCT04879433 ·Status: UNKNOWN

A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures

NCT01964560 ·Status: COMPLETED ·Phase: PHASE3

A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

NCT06132893 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Evaluate the Efficacy of BGG492 as Adjunctive Treatment in Patients With Refractory Partial Onset Seizures

NCT01167335 ·Status: WITHDRAWN ·Phase: PHASE2

Assess Safety and Efficacy of Lacosamide in Patients With Partial Seizures

NCT00515619 ·Status: COMPLETED ·Phase: PHASE3

Study for the Diagnosis and Treatment of Drug-resistant Focal Epilepsies

NCT06794606 ·Status: RECRUITING

Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures

NCT02687711 ·Status: COMPLETED

A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset Seizures

NCT00422110 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3

A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

NCT06315322 ·Status: RECRUITING ·Phase: PHASE3